Drug collection and use and then broadcast on the news! How to understand the four "highly valued"?

November 20 CCTV news broadcast: on November 20, the State Council held an executive meeting The meeting pointed out that promoting the centralized purchase and use of drugs is an important part of deepening medical reform, playing a positive role in reducing the "virtual high" drug price and reducing the burden of the masses The meeting called for further progress in this work First, expand the scope of centralized procurement and use, give priority to the varieties with large price difference between the original research drugs and generic drugs, and the basic drugs through the consistency evaluation of generic drugs into the centralized procurement, so as to promote the reduction of drug prices To build a national centralized procurement platform for drugs Second, establish the emergency reserve, inventory and capacity reporting system of bid winning enterprises to ensure the supply and quality safety of bid winning drugs Third, formulate and implement national drug administration measures, and promote medical institutions to use national essential drugs and Medicare drugs first On the premise of not increasing the burden of patients in general, we will explore the optimization of medical service price in a stable and orderly pilot Fourth, we will promote the reform of payment methods for medical insurance, and explore more efficient payment methods for drugs At the executive meeting of the State Council on April 3 this year, it was required to improve the centralized procurement system, strengthen the quality supervision and supply guarantee of bid winning drugs, and realize price reduction for the benefit of the people We will conscientiously summarize the experience of the pilot projects and push them forward in a timely and comprehensive manner In late September, the national joint mining and expansion project was launched Less than two months later, the executive meeting of the State Council again deployed the centralized purchase and use of research drugs This shows that the high-level attached great importance to this matter In April, the meeting was more of a sort and summary of the centralized procurement system, that is, "improve", "strengthen", "seriously summarize" and "timely and comprehensive", with the goal of "push away!" This meeting called for "further promoting the centralized purchase and use of drugs" The statement of promotion requires "accelerating the progress of things in progress" On the basis of promotion, this meeting emphasized the importance of "further promotion", which means "seize the day and night" At the meeting, it was proposed that "priority should be given to the varieties with large price difference between the original research drug and the generic drug, as well as the essential drugs through the generic drug consistency evaluation, etc to be included in the centralized procurement, so as to promote the drug price reduction", which has three meanings: The first is to focus on the original research and generic drugs with large price differences If the price difference is small (it can be recalled that the original research in some provinces and cities has taken the initiative to reduce prices, which is undoubtedly a correct strategy On the one hand, in order to meet the requirements of various catalogues or market share, on the other hand, we should actively lower ourselves to strive for long-term development If the price difference is large (the price of generic drugs is often one third or even one sixth of the original drugs), then the next round of national adoption will probably include such original research Second, we attach great importance to the basic drugs, especially the base drugs that have been evaluated Under the protection of the 1 + X policy, although such varieties face the situation of price for quantity, in the long run, there is more foundation to consolidate the market space The third meaning is that if the above two major problems are successfully solved, the drug price can be "promoted to reduce", and the ultimate goal is also obvious: the above two types of varieties will be the scope of key procurement in the future! On the one hand, the state has issued relevant payment standard policies to ensure that medical institutions do not affect the supply and use of selected drugs on the basis of cost control On the other hand, the bid winning enterprises are required to do a good job in supply guarantee, implement the independent selection of distribution enterprises by the production enterprises, standardize the distribution behavior through agreements, ensure the stability of supply, and prevent the appearance of bidding dead.